Oziltus
NDC 70121-2701, denosumab-mobz, injection, solution, from Amneal Pharmaceuticals LLC.
- Product NDC
- 70121-2701
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761457
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DENOSUMAB70 mg/mL
Pharmacologic classes
RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70121-2701-1 | 70121270101 | 1 VIAL in 1 CARTON (70121-2701-1) / 1.7 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f040a245-1be4-4962-a8b7-a13ee7fac707
Use it
Look up 70121-2701 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70121-2701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.